Straits Times Index
3,166.99 +13.76 (+0.44%) Nikkei
27,369.45 +248.92 (+0.92%) Hang Seng
18,010.18 -77.79 (-0.43%) FTSE 100
7,052.62 -33.84 (-0.48%) BTC-USD
20,400.61 +189.45 (+0.94%) CMC Crypto 200
463.20 +4.79 (+1.05%)
Organon & Co. (OGN)
After hours:
- CNW Group
Organon Canada reinforces the need to raise awareness and access for contraception methods with nearly half of pregnancies unplanned
On World Contraception Day (September 26), Organon (NYSE: OGN), a global women's health company, is launching Act with Her, a multi-faceted approach to help tackle the global health issue of unintended pregnancies (UIPs) and to improve access to contraception. Organon is proud to support the Society of Obstetricians and Gynaecologists of Canada (SOGC) to reinforce the importance of education and awareness in reducing unplanned pregnancies in Canada through roundtable discussions. In addition, Or
- Business Wire
Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA™ (adalimumab-bwwd)
INCHEON, Korea & JERSEY CITY, N.J., August 17, 2022--Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA™ (adalimumab-bwwd)
- Business Wire
Organon Reports Results for the Second Quarter Ended June 30, 2022
JERSEY CITY, N.J., August 04, 2022--Organon reports results for the second quarter ended June 30, 2022
